Cogent Biosciences Grants 22,000 Stock Options, 16,500 RSUs to Six New Employees

By Public Technologies20:01 (UTC), 27 October 2026 Updated

Cogent Biosciences granted equity awards to six new employees on October 26, 2026, under its 2020 Inducement Plan.
The awards comprised nonqualified options to purchase 22,000 common shares and 16,500 restricted stock units.
Options have 10-year terms, with 25% vesting on the grant date's first anniversary.
Remaining options vest in equal monthly installments over the subsequent 36 months; restricted stock units vest annually in equal installments over four years.
All vesting requires continued employment through each vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cogent Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610271601PRIMZONEFULLFEED9854346) on October 27, 2026, and is solely responsible for the information contained therein.